Pharmaceutical / Drug Definition :
Thought to cause differentiation of promyelocytic leukemic blast cells, leading to apoptosis (cell shrinkage and death) and cancer remission.
In the United States, Tretinoin is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Tretinoin.
Registrar Corp assists Tretinoin companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Tretinoin (Tretinoin Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Tretinoin (Tretinoin Suppliers)
- Processors Tretinoin
- Repackers Tretinoin
- Relabelers Tretinoin
- Exporters Tretinoin
- Importers Tretinoin
For more information about Tretinoin, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.